Peak Ten Capital’s AbbVie ABBV Stock Holding History

Peak Ten Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,000	Closed	-$654K	–	36
2014 Q4	$654K	Buy	+10,000	New	+$630K	0.64%	45
2013 Q3	–	Sell	-10,000	Closed	-$413K	–	45
2013 Q2	$413K	Buy	+10,000	New	+$437K	0.5%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Peak Ten Capital's ABBV Position: Q1 2015 in Review

Peak Ten Capital sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 10,000 shares — an estimated $654K sold.

Peak Ten Capital first reported a position in ABBV in Q2 2013 and held it in 2 quarters. The position peaked at $654K in Q4 2014. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Peak Ten Capital reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
Peak Ten Capital sold 10,000 AbbVie shares in Q1 2015, an estimated $654K.
Peak Ten Capital first reported a position in AbbVie in Q2 2013 and held it in 2 quarters.
Peak Ten Capital's AbbVie position peaked at $654K in Q4 2014.
1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Peak Ten Capital's 13F filing for Q1 2015, filed 11 May 2015.